Want to light up the pleasure center in your brain? Just pay your taxes, and then give a little extra voluntarily to your local food bank. University of Oregon scientists have found that doing those deeds can give you the same sort of satisfaction you derive from feeding your own hunger pangs.
More than half of the participants in experiments conducted at the University of York fail to plan ahead when making dynamic decisions about their lives, according to the findings of research funded by the Economic and Social Research Council that will have implications for policies on financial planning and pensions.
Adding to a growing body of evidence, new research shows that a daily dose of pistachios may offer protective benefits against cardiovascular disease, according to a study published in the Volume 26, No. 2 issue of the Journal of the American College of Nutrition.
Nearly half of all patients are currently being treated within 18 weeks, a year and a half ahead of schedule, according to the first official figures produced by the Department of Health today.
US President Bush disappointed in House Vote on Embryonic Stem Cell Bill. The following is a statement by US President Bush:
As a brain-damaged woman named Terri Schiavo lived her final days in 2005, her family’s bitter feuding imparted a tragic lesson about the importance of specifying one’s wishes for end-of-life medical treatment.
Risk is a ubiquitous component of the natural world and human life. Although some amount of risk-taking behaviour is desirable and essential for human survival and advancement, excessive risk-taking may underlie pathological conditions such as drug-abuse and compulsive gambling.
A report released by the American Legacy Foundation says that American youth continue to show strong preferences for specific cigarette types, many of which are heavily marketed.
Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades.
In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study, according to an analysis of nearly 200 statin-drug comparisons carried out between 1999 and 2005.